BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33059240)

  • 21. miR-125a-3p suppresses the growth and progression of papillary thyroid carcinoma cell by targeting MMP11.
    Song M; Wang N; Li Z; Zhang Y; Zheng Y; Yi P; Chen J
    J Cell Biochem; 2020 Feb; 121(2):984-995. PubMed ID: 31489990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
    Zhou SL; Tang QL; Zhou SX; Ren RZ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.
    Jiang Y; Liu Y; Zhang Y; Ouyang J; Feng Y; Li S; Wang J; Zhang C; Tan L; Zhong J; Zou L
    Cell Signal; 2023 Sep; 109():110792. PubMed ID: 37406787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
    Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
    Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J
    Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
    Chen N; Yin D; Lun B; Guo X
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
    Feng Z; Chen R; Huang N; Luo C
    Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircLDLR Promotes Papillary Thyroid Carcinoma Tumorigenicity by Regulating miR-637/LMO4 Axis.
    Jiang YM; Liu W; Jiang L; Chang H
    Dis Markers; 2021; 2021():3977189. PubMed ID: 34925640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
    Bai X; Xu Y; Liu Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.
    Ding C; Shi T; Wu G; Man J; Han H; Cui Y
    Bioengineered; 2022 Mar; 13(3):6629-6640. PubMed ID: 35213273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of long noncoding RNA LINC00324 restricts cell proliferation and invasion of papillary thyroid carcinoma through downregulation of TRIM29 via upregulating microRNA-195-5p.
    Xu J; Li Z; Su Q; Zhao J; Ma J
    Aging (Albany NY); 2020 Dec; 12(24):26000-26011. PubMed ID: 33318312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-222-3p promotes the proliferation, migration and invasion of papillary thyroid carcinoma cells through targeting SLC4A4.
    Zhang C; Chang Q; Hu Y; Chang W; Guo X; Fu L; Tang G; Chen C
    Histol Histopathol; 2021 Nov; 36(11):1199-1207. PubMed ID: 34708859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer.
    Feng L; Wang R; Yang Y; Shen X; Shi Q; Lian M; Ma H; Fang J
    Life Sci; 2021 Jan; 265():118743. PubMed ID: 33188837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma.
    Kong W; Yang L; Li PP; Kong QQ; Wang HY; Han GX; Wang QB
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3804-3811. PubMed ID: 29949156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIR22HG inhibits cell growth, migration and invasion through regulating the miR-24-3p/p27kip1 axis in thyroid papillary carcinomas.
    Chen ZB; Cao WL; Su K; Mao M; Zeng XY; Li JH
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5851-5862. PubMed ID: 31298336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2.
    Wang ZL; Wang C; Liu W; Ai ZL
    Exp Mol Pathol; 2020 Feb; 112():104342. PubMed ID: 31738908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
    Geraldo MV; Nakaya HI; Kimura ET
    Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.